Evaxion Biotech Appoints Marianne Søgaard as Chairwoman

COPENHAGEN, Denmark, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S, a clinical-stage biotechnology company developing AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases, announced today the appointment of previously practicing commercial, technology and corporate lawyer Marianne Søgaard as Chairwoman of the Board of Directors.

Read the original here:
Evaxion Biotech Appoints Marianne Søgaard as Chairwoman

Related Post